Tower Research Capital LLC (Trc) Belite Bio, Inc Transaction History
Tower Research Capital LLC (Trc)
- $3.29 Billion
- Q1 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Belite Bio, Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 14 shares of BLTE stock, worth $901. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14Holding current value
$901% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BLTE
# of Institutions
19Shares Held
270KCall Options Held
0Put Options Held
0-
Gamma Investing LLC Foster City, CA122KShares$7.89 Million0.01% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL83.6KShares$5.39 Million0.02% of portfolio
-
State Street Corp Boston, MA20.1KShares$1.29 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA12.8KShares$821,2930.0% of portfolio
-
Jpmorgan Chase & CO New York, NY8.16KShares$525,6320.0% of portfolio
About BELITE BIO, INC
- Ticker BLTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,867,400
- Market Cap $1.6B
- Description
- Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery o...